Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 81 entries
Sorted by: Best Match Show Resources per page
Characteristics of COVID-19 in patients with multiple sclerosis.

Multiple sclerosis and related disorders

Ghadiri F, Sahraian MA, Shaygannejad V, Ashtari F, Ghalyanchi H, Baghbanian SM, Mojdehipanah H, Majdi-Nasab N, Hosseini S, Poursadeghfard M, Beladimoghadam N, Razazian N, Ayoubi S, Rezaeimanesh N, Eskandarieh S, Naser Moghadasi A.
PMID: 34896875
Mult Scler Relat Disord. 2021 Nov 30;57:103437. doi: 10.1016/j.msard.2021.103437. Epub 2021 Nov 30.

BACKGROUND: Regarding the high prevalence of multiple sclerosis (MS) and COVID-19 in Iran, a multicenter study of COVID-19 in Iranian MS patients with is carried out to address the concerns of this population.METHODS: Data on MS patients with COVID-19...

Cite
Ghadiri F, Sahraian MA, Shaygannejad V, et al. Characteristics of COVID-19 in patients with multiple sclerosis. Mult Scler Relat Disord. 2021;57:103437doi: 10.1016/j.msard.2021.103437.
Ghadiri, F., Sahraian, M. A., Shaygannejad, V., Ashtari, F., Ghalyanchi, H., Baghbanian, S. M., Mojdehipanah, H., Majdi-Nasab, N., Hosseini, S., Poursadeghfard, M., Beladimoghadam, N., Razazian, N., Ayoubi, S., Rezaeimanesh, N., Eskandarieh, S., & Naser Moghadasi, A. (2021). Characteristics of COVID-19 in patients with multiple sclerosis. Multiple sclerosis and related disorders, 57103437. https://doi.org/10.1016/j.msard.2021.103437
Ghadiri, Fereshteh, et al. "Characteristics of COVID-19 in patients with multiple sclerosis." Multiple sclerosis and related disorders vol. 57 (2021): 103437. doi: https://doi.org/10.1016/j.msard.2021.103437
Ghadiri F, Sahraian MA, Shaygannejad V, Ashtari F, Ghalyanchi H, Baghbanian SM, Mojdehipanah H, Majdi-Nasab N, Hosseini S, Poursadeghfard M, Beladimoghadam N, Razazian N, Ayoubi S, Rezaeimanesh N, Eskandarieh S, Naser Moghadasi A. Characteristics of COVID-19 in patients with multiple sclerosis. Mult Scler Relat Disord. 2021 Nov 30;57:103437. doi: 10.1016/j.msard.2021.103437. Epub 2021 Nov 30. PMID: 34896875; PMCID: PMC8629769.
Copy Download .nbib Format: NLM
Antibodies to neutralising epitopes synergistically block the interaction of the receptor-binding domain of SARS-CoV-2 to ACE 2.

Clinical & translational immunology

Pandey M, Ozberk V, Eskandari S, Shalash AO, Joyce MA, Saffran HA, Day CJ, Lepletier A, Spillings BL, Mills JL, Calcutt A, Fan F, Williams JT, Stanisic DI, Hattingh L, Gerrard J, Skwarczynski M, Mak J, Jennings MP, Toth I, Tyrrell DL, Good MF.
PMID: 33732459
Clin Transl Immunology. 2021 Mar 07;10(3):e1260. doi: 10.1002/cti2.1260. eCollection 2021.

OBJECTIVES: A major COVID-19 vaccine strategy is to induce antibodies that prevent interaction between the Spike protein's receptor-binding domain (RBD) and angiotensin-converting enzyme 2 (ACE2). These vaccines will also induce T-cell responses. However, concerns were raised that aberrant vaccine-induced...

Cite
Pandey M, Ozberk V, Eskandari S, et al. Antibodies to neutralising epitopes synergistically block the interaction of the receptor-binding domain of SARS-CoV-2 to ACE 2. Clin Transl Immunology. 2021;10(3):e1260doi: 10.1002/cti2.1260.
Pandey, M., Ozberk, V., Eskandari, S., Shalash, A. O., Joyce, M. A., Saffran, H. A., Day, C. J., Lepletier, A., Spillings, B. L., Mills, J. L., Calcutt, A., Fan, F., Williams, J. T., Stanisic, D. I., Hattingh, L., Gerrard, J., Skwarczynski, M., Mak, J., Jennings, M. P., Toth, I., Tyrrell, D. L., & Good, M. F. (2021). Antibodies to neutralising epitopes synergistically block the interaction of the receptor-binding domain of SARS-CoV-2 to ACE 2. Clinical & translational immunology, 10(3), e1260. https://doi.org/10.1002/cti2.1260
Pandey, Manisha, et al. "Antibodies to neutralising epitopes synergistically block the interaction of the receptor-binding domain of SARS-CoV-2 to ACE 2." Clinical & translational immunology vol. 10,3 (2021): e1260. doi: https://doi.org/10.1002/cti2.1260
Pandey M, Ozberk V, Eskandari S, Shalash AO, Joyce MA, Saffran HA, Day CJ, Lepletier A, Spillings BL, Mills JL, Calcutt A, Fan F, Williams JT, Stanisic DI, Hattingh L, Gerrard J, Skwarczynski M, Mak J, Jennings MP, Toth I, Tyrrell DL, Good MF. Antibodies to neutralising epitopes synergistically block the interaction of the receptor-binding domain of SARS-CoV-2 to ACE 2. Clin Transl Immunology. 2021 Mar 07;10(3):e1260. doi: 10.1002/cti2.1260. eCollection 2021. PMID: 33732459; PMCID: PMC7937407.
Copy Download .nbib Format: NLM
Discovery and Validation of a Urinary Exosome mRNA Signature for the Diagnosis of Human Kidney Transplant Rejection.

Journal of the American Society of Nephrology : JASN

El Fekih R, Hurley J, Tadigotla V, Alghamdi A, Srivastava A, Coticchia C, Choi J, Allos H, Yatim K, Alhaddad J, Eskandari S, Chu P, Mihali AB, Lape IT, Lima Filho MP, Aoyama BT, Chandraker A, Safa K, Markmann JF, Riella LV, Formica RN, Skog J, Azzi JR.
PMID: 33658284
J Am Soc Nephrol. 2021 Mar 03; doi: 10.1681/ASN.2020060850. Epub 2021 Mar 03.

BACKGROUND: Developing a noninvasive clinical test to accurately diagnose kidney allograft rejection is critical to improve allograft outcomes. Urinary exosomes, tiny vesicles released into the urine that carry parent cells' proteins and nucleic acids, reflect the biologic function of...

Cite
El Fekih R, Hurley J, Tadigotla V, et al. Discovery and Validation of a Urinary Exosome mRNA Signature for the Diagnosis of Human Kidney Transplant Rejection. J Am Soc Nephrol. 2021;doi: 10.1681/ASN.2020060850.
El Fekih, R., Hurley, J., Tadigotla, V., Alghamdi, A., Srivastava, A., Coticchia, C., Choi, J., Allos, H., Yatim, K., Alhaddad, J., Eskandari, S., Chu, P., Mihali, A. B., Lape, I. T., Lima Filho, M. P., Aoyama, B. T., Chandraker, A., Safa, K., Markmann, J. F., Riella, L. V., Formica, R. N., Skog, J., & Azzi, J. R. (2021). Discovery and Validation of a Urinary Exosome mRNA Signature for the Diagnosis of Human Kidney Transplant Rejection. Journal of the American Society of Nephrology : JASN, . https://doi.org/10.1681/ASN.2020060850
El Fekih, Rania, et al. "Discovery and Validation of a Urinary Exosome mRNA Signature for the Diagnosis of Human Kidney Transplant Rejection." Journal of the American Society of Nephrology : JASN vol. (2021). doi: https://doi.org/10.1681/ASN.2020060850
El Fekih R, Hurley J, Tadigotla V, Alghamdi A, Srivastava A, Coticchia C, Choi J, Allos H, Yatim K, Alhaddad J, Eskandari S, Chu P, Mihali AB, Lape IT, Lima Filho MP, Aoyama BT, Chandraker A, Safa K, Markmann JF, Riella LV, Formica RN, Skog J, Azzi JR. Discovery and Validation of a Urinary Exosome mRNA Signature for the Diagnosis of Human Kidney Transplant Rejection. J Am Soc Nephrol. 2021 Mar 03; doi: 10.1681/ASN.2020060850. Epub 2021 Mar 03. PMID: 33658284; PMCID: PMC8017553.
Copy Download .nbib Format: NLM
Polymerization behavior and thermal characteristics of two new composites at five temperatures: refrigeration to preheating.

The journal of advanced prosthodontics

Jafarzadeh-Kashi TS, Mirzaii M, Erfan M, Fazel A, Eskandarion S, Rakhshan V.
PMID: 22259705
J Adv Prosthodont. 2011 Dec;3(4):216-20. doi: 10.4047/jap.2011.3.4.216. Epub 2011 Dec 28.

PURPOSE: Heat of composite polymerization (HP) indicates setting efficacy and temperature increase of composite in clinical procedures. The purpose of this in vitro experimental study was to evaluate the effects of 5 temperatures on HP of two new composites.MATERIALS...

Cite
Jafarzadeh-Kashi TS, Mirzaii M, Erfan M, et al. Polymerization behavior and thermal characteristics of two new composites at five temperatures: refrigeration to preheating. J Adv Prosthodont. 2011;3(4):216-20doi: 10.4047/jap.2011.3.4.216.
Jafarzadeh-Kashi, T. S., Mirzaii, M., Erfan, M., Fazel, A., Eskandarion, S., & Rakhshan, V. (2011). Polymerization behavior and thermal characteristics of two new composites at five temperatures: refrigeration to preheating. The journal of advanced prosthodontics, 3(4), 216-20. https://doi.org/10.4047/jap.2011.3.4.216
Jafarzadeh-Kashi, Tahereh Sadat, et al. "Polymerization behavior and thermal characteristics of two new composites at five temperatures: refrigeration to preheating." The journal of advanced prosthodontics vol. 3,4 (2011): 216-20. doi: https://doi.org/10.4047/jap.2011.3.4.216
Jafarzadeh-Kashi TS, Mirzaii M, Erfan M, Fazel A, Eskandarion S, Rakhshan V. Polymerization behavior and thermal characteristics of two new composites at five temperatures: refrigeration to preheating. J Adv Prosthodont. 2011 Dec;3(4):216-20. doi: 10.4047/jap.2011.3.4.216. Epub 2011 Dec 28. PMID: 22259705; PMCID: PMC3259447.
Copy Download .nbib Format: NLM
Absorption of daunorubicin and etoposide drugs by hydroxylated and carboxylated carbon nanotube for drug delivery: theoretical and experimental studies.

Journal of biomolecular structure & dynamics

Eskandari S, Barzegar A, Mahnam K.
PMID: 34166598
J Biomol Struct Dyn. 2021 Jun 24;1-8. doi: 10.1080/07391102.2021.1938232. Epub 2021 Jun 24.

Anti-cancer daunorubicin and etoposide drugs are mostly used in chemotherapy medicine to treat a wide variety of cancers. Many of the side effects and specific delivery to a target tissue are the main challenges of using chemotherapeutic agents. To...

Cite
Eskandari S, Barzegar A, Mahnam K. Absorption of daunorubicin and etoposide drugs by hydroxylated and carboxylated carbon nanotube for drug delivery: theoretical and experimental studies. J Biomol Struct Dyn. 2021;1-8doi: 10.1080/07391102.2021.1938232.
Eskandari, S., Barzegar, A., & Mahnam, K. (2021). Absorption of daunorubicin and etoposide drugs by hydroxylated and carboxylated carbon nanotube for drug delivery: theoretical and experimental studies. Journal of biomolecular structure & dynamics, 1-8. https://doi.org/10.1080/07391102.2021.1938232
Eskandari, Sara, et al. "Absorption of daunorubicin and etoposide drugs by hydroxylated and carboxylated carbon nanotube for drug delivery: theoretical and experimental studies." Journal of biomolecular structure & dynamics vol. (2021): 1-8. doi: https://doi.org/10.1080/07391102.2021.1938232
Eskandari S, Barzegar A, Mahnam K. Absorption of daunorubicin and etoposide drugs by hydroxylated and carboxylated carbon nanotube for drug delivery: theoretical and experimental studies. J Biomol Struct Dyn. 2021 Jun 24;1-8. doi: 10.1080/07391102.2021.1938232. Epub 2021 Jun 24. PMID: 34166598.
Copy Download .nbib Format: NLM
Characteristics of COVID-19 in patients with multiple sclerosis.

Multiple sclerosis and related disorders

Ghadiri F, Sahraian MA, Shaygannejad V, Ashtari F, Ghalyanchi Langroodi H, Baghbanian SM, Mozhdehipanah H, Majdi-Nasab N, Hosseini S, Poursadeghfard M, Beladimoghadam N, Razazian N, Ayoubi S, Rezaeimanesh N, Eskandarieh S, Naser Moghadasi A.
PMID: 34896875
Mult Scler Relat Disord. 2021 Nov 30;57:103437. doi: 10.1016/j.msard.2021.103437. Epub 2021 Nov 30.

BACKGROUND: Regarding the high prevalence of multiple sclerosis (MS) and COVID-19 in Iran, a multicenter study of COVID-19 in Iranian MS patients with is carried out to address the concerns of this population.METHODS: Data on MS patients with COVID-19...

Cite
Ghadiri F, Sahraian MA, Shaygannejad V, et al. Characteristics of COVID-19 in patients with multiple sclerosis. Mult Scler Relat Disord. 2021;57:103437doi: 10.1016/j.msard.2021.103437.
Ghadiri, F., Sahraian, M. A., Shaygannejad, V., Ashtari, F., Ghalyanchi Langroodi, H., Baghbanian, S. M., Mozhdehipanah, H., Majdi-Nasab, N., Hosseini, S., Poursadeghfard, M., Beladimoghadam, N., Razazian, N., Ayoubi, S., Rezaeimanesh, N., Eskandarieh, S., & Naser Moghadasi, A. (2021). Characteristics of COVID-19 in patients with multiple sclerosis. Multiple sclerosis and related disorders, 57103437. https://doi.org/10.1016/j.msard.2021.103437
Ghadiri, Fereshteh, et al. "Characteristics of COVID-19 in patients with multiple sclerosis." Multiple sclerosis and related disorders vol. 57 (2021): 103437. doi: https://doi.org/10.1016/j.msard.2021.103437
Ghadiri F, Sahraian MA, Shaygannejad V, Ashtari F, Ghalyanchi Langroodi H, Baghbanian SM, Mozhdehipanah H, Majdi-Nasab N, Hosseini S, Poursadeghfard M, Beladimoghadam N, Razazian N, Ayoubi S, Rezaeimanesh N, Eskandarieh S, Naser Moghadasi A. Characteristics of COVID-19 in patients with multiple sclerosis. Mult Scler Relat Disord. 2021 Nov 30;57:103437. doi: 10.1016/j.msard.2021.103437. Epub 2021 Nov 30. PMID: 34896875; PMCID: PMC8629769.
Copy Download .nbib Format: NLM
Characteristics of COVID-19 in patients with multiple sclerosis.

Multiple sclerosis and related disorders

Ghadiri F, Sahraian MA, Shaygannejad V, Ashtari F, Ghalyanchi H, Baghbanian SM, Mojdehipanah H, Majdi-Nasab N, Hosseini S, Poursadeghfard M, Beladimoghadam N, Razazian N, Ayoubi S, Rezaeimanesh N, Eskandarieh S, Naser Moghadasi A.
PMID: 34896875
Mult Scler Relat Disord. 2021 Nov 30;57:103437. doi: 10.1016/j.msard.2021.103437. Epub 2021 Nov 30.

BACKGROUND: Regarding the high prevalence of multiple sclerosis (MS) and COVID-19 in Iran, a multicenter study of COVID-19 in Iranian MS patients with is carried out to address the concerns of this population.METHODS: Data on MS patients with COVID-19...

Cite
Ghadiri F, Sahraian MA, Shaygannejad V, et al. Characteristics of COVID-19 in patients with multiple sclerosis. Mult Scler Relat Disord. 2021;57:103437doi: 10.1016/j.msard.2021.103437.
Ghadiri, F., Sahraian, M. A., Shaygannejad, V., Ashtari, F., Ghalyanchi, H., Baghbanian, S. M., Mojdehipanah, H., Majdi-Nasab, N., Hosseini, S., Poursadeghfard, M., Beladimoghadam, N., Razazian, N., Ayoubi, S., Rezaeimanesh, N., Eskandarieh, S., & Naser Moghadasi, A. (2021). Characteristics of COVID-19 in patients with multiple sclerosis. Multiple sclerosis and related disorders, 57103437. https://doi.org/10.1016/j.msard.2021.103437
Ghadiri, Fereshteh, et al. "Characteristics of COVID-19 in patients with multiple sclerosis." Multiple sclerosis and related disorders vol. 57 (2021): 103437. doi: https://doi.org/10.1016/j.msard.2021.103437
Ghadiri F, Sahraian MA, Shaygannejad V, Ashtari F, Ghalyanchi H, Baghbanian SM, Mojdehipanah H, Majdi-Nasab N, Hosseini S, Poursadeghfard M, Beladimoghadam N, Razazian N, Ayoubi S, Rezaeimanesh N, Eskandarieh S, Naser Moghadasi A. Characteristics of COVID-19 in patients with multiple sclerosis. Mult Scler Relat Disord. 2021 Nov 30;57:103437. doi: 10.1016/j.msard.2021.103437. Epub 2021 Nov 30. PMID: 34896875.
Copy Download .nbib Format: NLM
Finite element analysis of stress distribution around short and long implants in mandibular overdenture treatment.

Dental research journal

Memari Y, Fattahi P, Fattahi A, Eskandarion S, Rakhshan V.
PMID: 32055290
Dent Res J (Isfahan). 2020 Jan 21;17(1):25-33. eCollection 2020.

BACKGROUND: Optimal stress distribution around implants plays an important role in the success of mandibular overdentures. This study sought to assess the pattern of stress distribution around short (6 mm) and long (10 mm) implants in mandibular two implant-supported...

Cite
Memari Y, Fattahi P, Fattahi A, et al. Finite element analysis of stress distribution around short and long implants in mandibular overdenture treatment. Dent Res J (Isfahan). 2020;17(1):25-33
Memari, Y., Fattahi, P., Fattahi, A., Eskandarion, S., & Rakhshan, V. (2020). Finite element analysis of stress distribution around short and long implants in mandibular overdenture treatment. Dental research journal, 17(1), 25-33.
Memari, Yeghaneh, et al. "Finite element analysis of stress distribution around short and long implants in mandibular overdenture treatment." Dental research journal vol. 17,1 (2020): 25-33.
Memari Y, Fattahi P, Fattahi A, Eskandarion S, Rakhshan V. Finite element analysis of stress distribution around short and long implants in mandibular overdenture treatment. Dent Res J (Isfahan). 2020 Jan 21;17(1):25-33. eCollection 2020. PMID: 32055290; PMCID: PMC7001565.
Copy Download .nbib Format: NLM
Viruses and long non-coding RNAs: implicating an evolutionary conserved region.

Virusdisease

Mohebbi A, Tahamtan A, Eskandarian S, Askari FS, Shafaei M, Lorestani N.
PMID: 30539050
Virusdisease. 2018 Dec;29(4):478-485. doi: 10.1007/s13337-018-0486-9. Epub 2018 Sep 24.

Long non-coding RNAs (lncRNAs) are a class of cellular transcripts, which are involved in various biological processes. There is conflicting data regarding to the origin of these non-coding molecules and lncRNAs are thought to be the origin of viral...

Cite
Mohebbi A, Tahamtan A, Eskandarian S, et al. Viruses and long non-coding RNAs: implicating an evolutionary conserved region. Virusdisease. 2018;29(4):478-485doi: 10.1007/s13337-018-0486-9.
Mohebbi, A., Tahamtan, A., Eskandarian, S., Askari, F. S., Shafaei, M., & Lorestani, N. (2018). Viruses and long non-coding RNAs: implicating an evolutionary conserved region. Virusdisease, 29(4), 478-485. https://doi.org/10.1007/s13337-018-0486-9
Mohebbi, Alireza, et al. "Viruses and long non-coding RNAs: implicating an evolutionary conserved region." Virusdisease vol. 29,4 (2018): 478-485. doi: https://doi.org/10.1007/s13337-018-0486-9
Mohebbi A, Tahamtan A, Eskandarian S, Askari FS, Shafaei M, Lorestani N. Viruses and long non-coding RNAs: implicating an evolutionary conserved region. Virusdisease. 2018 Dec;29(4):478-485. doi: 10.1007/s13337-018-0486-9. Epub 2018 Sep 24. PMID: 30539050; PMCID: PMC6261887.
Copy Download .nbib Format: NLM
Validation of the Persian version of the Pittsburgh Sleep Quality Index in elderly population.

Sleep science (Sao Paulo, Brazil)

Chehri A, Nourozi M, Eskandari S, Khazaie H, Hemati N, Jalali A, Holmqvist M.
PMID: 32742582
Sleep Sci. 2020 Apr-Jun;13(2):119-124. doi: 10.5935/1984-0063.20190134.

OBJECTIVE: The purpose of this study is to determine the validity and reliability of the Persian version of the Pittsburgh Sleep Quality Index in the elderly population.MATERIAL AND METHODS: A methodological study was conducted as a confirmatory factor analysis....

Cite
Chehri A, Nourozi M, Eskandari S, et al. Validation of the Persian version of the Pittsburgh Sleep Quality Index in elderly population. Sleep Sci. 2020;13(2):119-124doi: 10.5935/1984-0063.20190134.
Chehri, A., Nourozi, M., Eskandari, S., Khazaie, H., Hemati, N., Jalali, A., & Holmqvist, M. (2020). Validation of the Persian version of the Pittsburgh Sleep Quality Index in elderly population. Sleep science (Sao Paulo, Brazil), 13(2), 119-124. https://doi.org/10.5935/1984-0063.20190134
Chehri, Azita, et al. "Validation of the Persian version of the Pittsburgh Sleep Quality Index in elderly population." Sleep science (Sao Paulo, Brazil) vol. 13,2 (2020): 119-124. doi: https://doi.org/10.5935/1984-0063.20190134
Chehri A, Nourozi M, Eskandari S, Khazaie H, Hemati N, Jalali A, Holmqvist M. Validation of the Persian version of the Pittsburgh Sleep Quality Index in elderly population. Sleep Sci. 2020 Apr-Jun;13(2):119-124. doi: 10.5935/1984-0063.20190134. PMID: 32742582; PMCID: PMC7384532.
Copy Download .nbib Format: NLM
Fissure sealant materials: Wear resistance of flowable composite resins.

Journal of dental research, dental clinics, dental prospects

Asefi S, Eskandarion S, Hamidiaval S.
PMID: 27651887
J Dent Res Dent Clin Dent Prospects. 2016;10(3):194-9. doi: 10.15171/joddd.2016.031. Epub 2016 Aug 17.

Background. Wear resistance of pit and fissure sealant materials can influence their retention. Wear characteristics of sealant materials may determine scheduling of check-up visits. The aim of this study was to compare wear resistance of two flowable composite resins...

Cite
Asefi S, Eskandarion S, Hamidiaval S. Fissure sealant materials: Wear resistance of flowable composite resins. J Dent Res Dent Clin Dent Prospects. 2016;10(3):194-9doi: 10.15171/joddd.2016.031.
Asefi, S., Eskandarion, S., & Hamidiaval, S. (2016). Fissure sealant materials: Wear resistance of flowable composite resins. Journal of dental research, dental clinics, dental prospects, 10(3), 194-9. https://doi.org/10.15171/joddd.2016.031
Asefi, Sohrab, et al. "Fissure sealant materials: Wear resistance of flowable composite resins." Journal of dental research, dental clinics, dental prospects vol. 10,3 (2016): 194-9. doi: https://doi.org/10.15171/joddd.2016.031
Asefi S, Eskandarion S, Hamidiaval S. Fissure sealant materials: Wear resistance of flowable composite resins. J Dent Res Dent Clin Dent Prospects. 2016;10(3):194-9. doi: 10.15171/joddd.2016.031. Epub 2016 Aug 17. PMID: 27651887; PMCID: PMC5025222.
Copy Download .nbib Format: NLM
[Relationship between patent foramen ovale and COVID-19 in patients admitted to an intensive care unit].

Revista espanola de cardiologia

Eskandari S, Jalali P.
PMID: 34092897
Rev Esp Cardiol. 2021 Aug;74(8):725-726. doi: 10.1016/j.recesp.2021.04.012. Epub 2021 Jun 01.

No abstract available.

Cite
Eskandari S, Jalali P. Foramen oval permeable en pacientes ingresados por COVID-19 en cuidados intensivos. [Relationship between patent foramen ovale and COVID-19 in patients admitted to an intensive care unit]. Rev Esp Cardiol. 2021;74(8):725-726doi: 10.1016/j.recesp.2021.04.012.
Eskandari, S., & Jalali, P. (2021). Foramen oval permeable en pacientes ingresados por COVID-19 en cuidados intensivos. [Relationship between patent foramen ovale and COVID-19 in patients admitted to an intensive care unit]. Revista espanola de cardiologia, 74(8), 725-726. https://doi.org/10.1016/j.recesp.2021.04.012
Eskandari, Saber, and Jalali, Pooya. "Foramen oval permeable en pacientes ingresados por COVID-19 en cuidados intensivos." [Relationship between patent foramen ovale and COVID-19 in patients admitted to an intensive care unit]. Revista espanola de cardiologia vol. 74,8 (2021): 725-726. doi: https://doi.org/10.1016/j.recesp.2021.04.012
Eskandari S, Jalali P. Foramen oval permeable en pacientes ingresados por COVID-19 en cuidados intensivos. [Relationship between patent foramen ovale and COVID-19 in patients admitted to an intensive care unit]. Rev Esp Cardiol. 2021 Aug;74(8):725-726. doi: 10.1016/j.recesp.2021.04.012. Epub 2021 Jun 01. Spanish. PMID: 34092897; PMCID: PMC8166536.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 81 entries